Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
170
Pancreatic enzyme supplementation for critically ill patients on enteral nutrition
Placebo of Pancreatic enzyme for critically ill patients on enteral nutrition
Seoul National University Hospital
Seoul, Jongno-gu, South Korea
RECRUITINGChange of Phase angle (°)
Change from Baseline Phase angle (°) at 2 weeks or discharge
Time frame: Baseline, 7 days after starting enteral nutrition, 14 days after starting enteral nutrition
Skeletal Muscle Mass (SMM) (kg)
Skeletal Muscle Mass (SMM) (kg)
Time frame: Baseline, 7 days after starting enteral nutrition, 14 days after starting enteral nutrition
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.